Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 11 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 9505826

    Modified antibody with improved half-life

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  2. US 9498544

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  3. US 9493757

    Modified factor VII or factor VIIa polypeptides

    Regents of the University of Minnesota · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  4. US 9476037

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  5. US 9469664

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Sarepta Therapeutics, Inc. · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted

  6. US 9457075

    Modified foot and mouth disease virus (FMDV) VP1 capsid protein

    The Pirbright Institute · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  7. US 9453239

    Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

    The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  8. US 9453078

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  9. US 9446067

    Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  10. US 9447406

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  11. US 9421204

    Oligomer modified diaromatic substituted compounds

    Nektar Therapeutics · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  12. US 9416360

    Base modified oligonucleotides

    MIRAGEN THERAPEUTICS, INC. · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  13. US 9394540

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  14. US 9388104

    Chemically modified small molecules

    Nektar Therapeutics · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  15. US 9388222

    Modified Pseudomonas exotoxin A

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  16. US 9371352

    Modified glycolipids and methods of making and using the same

    VACCINEX, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  17. US 9370525

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  18. US 9351975

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted

  19. US 9328140

    Modified mini-hepcidin peptides and methods of using thereof

    The Regents of the University of California · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  20. US 9328339

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  21. US 9321799

    Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

    Ionis Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  22. US 9320814

    Polyplexes of hydrophobically-modified siRNA for delivery of siRNA

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  23. US 9301509

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  24. US 9303068

    D-amino acid derivative-modified peptidoglycan and methods of use thereof

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.